Pulmonary consolidation and inflammation: inflammatory pseudotumour in young children

C A Lindemans1, R A Bruinsma, P G J Nikkels

  • 1Department of Pediatrics, Gelre Hospitals, Lukas location, The Netherlands. c.a.lindemans@umcutrecht.nl

Insights

Pulmonary inflammatory pseudotumours are rare in children and can mimic pneumonia. Early recognition and treatment are crucial to prevent serious outcomes, even in infants.

Area of Science:

  • Pediatric Pulmonology
  • Pediatric Oncology
  • Pediatric Pathology

Background:

  • Pulmonary inflammatory pseudotumours (PIPT) are rare neoplastic-like lesions.
  • They often present insidiously, mimicking infectious processes like pneumonia.
  • Early diagnosis is critical due to potential for significant morbidity.

Observation:

  • Two pediatric cases of PIPT are presented.
  • One patient was an infant as young as 6 months, highlighting rarity in very young children.
  • Clinical presentation, diagnostic challenges, and management approaches were observed.

Findings:

  • PIPT can present as a solid lung lesion that may not resolve or could progress.
  • The condition poses diagnostic challenges, especially in infants.
  • Management strategies and prognosis vary, emphasizing the need for individualized care.

Implications:

  • This condition should be considered in pediatric patients with persistent or progressing inflammatory lung conditions.
  • Awareness among clinicians is vital for timely diagnosis and appropriate management.
  • Further research into PIPT in children may improve understanding and treatment outcomes.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: